Trials / Terminated
TerminatedNCT02928289
Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma
Multi-Center Prospective Randomized Controlled Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 System in Canaloplasty vs Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Sight Sciences, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in reducing intraocular pressure (IOP) in adult, pseudophakic subjects with open-angle glaucoma.
Detailed description
This is a randomized study comparing viscodilation with the VISCO360 device to selective laser trabeculoplasty. Subjects with mild to moderate primary open-angle glaucoma undergo IOP-lowering medication washout at baseline and at Month 12. Subjects will be followed through Month 24.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VISCO360 ab interno canaloplasty surgery | 360 degrees of viscodilation of Schlemm's canal |
| DEVICE | Selective Laser Trabeculoplasty (SLT) | 360 degrees of selective laser trabeculoplasty |
Timeline
- Start date
- 2017-01-23
- Primary completion
- 2019-01-17
- Completion
- 2019-01-17
- First posted
- 2016-10-10
- Last updated
- 2025-11-14
- Results posted
- 2025-09-24
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02928289. Inclusion in this directory is not an endorsement.